BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33260945)

  • 21. Recent Research Progress in Fluorescent Probes for Detection of Amyloid-β In Vivo.
    Zhang ZY; Li ZJ; Tang YH; Xu L; Zhang DT; Qin TY; Wang YL
    Biosensors (Basel); 2023 Nov; 13(11):. PubMed ID: 37998165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functionalization of stable fluorescent nanodiamonds towards reliable detection of biomarkers for Alzheimer's disease.
    Morales-Zavala F; Casanova-Morales N; Gonzalez RB; Chandía-Cristi A; Estrada LD; Alvizú I; Waselowski V; Guzman F; Guerrero S; Oyarzún-Olave M; Rebolledo C; Rodriguez E; Armijo J; Bhuyan H; Favre M; Alvarez AR; Kogan MJ; Maze JR
    J Nanobiotechnology; 2018 Aug; 16(1):60. PubMed ID: 30097010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A near-infrared probe for detecting and interposing amyloid beta oligomerization in early Alzheimer's disease.
    Quan L; Moreno-Gonzalez I; Xie Z; Gamez N; Vegas-Gomez L; Song Q; Gu J; Lin W; Gomez-Gutierrez R; Wu T
    Alzheimers Dement; 2023 Feb; 19(2):456-466. PubMed ID: 35436382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N,O-Benzamide difluoroboron complexes as near-infrared probes for the detection of β-amyloid and tau fibrils.
    Chen Y; Yuan C; Xie T; Li Y; Dai B; Zhou K; Liang Y; Dai J; Tan H; Cui M
    Chem Commun (Camb); 2020 Jul; 56(53):7269-7272. PubMed ID: 32475993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immobilized Amyloid Hexamer Fragments to Map Active Sites of Amyloid-Targeting Chemicals.
    Cho I; Yoon S; Park S; Hong SW; Cho E; Kim E; Kim HY; Kim Y
    ACS Chem Neurosci; 2023 Jan; 14(1):9-18. PubMed ID: 36445044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deep Red Blinking Fluorophore for Nanoscopic Imaging and Inhibition of β-Amyloid Peptide Fibrillation.
    Ma Y; Ye Z; Zhang C; Wang X; Li HW; Wong MS; Luo HB; Xiao L
    ACS Nano; 2020 Sep; 14(9):11341-11351. PubMed ID: 32857496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular imaging of β-amyloid plaques with near-infrared boron dipyrromethane (BODIPY)-based fluorescent probes.
    Watanabe H; Ono M; Matsumura K; Yoshimura M; Kimura H; Saji H
    Mol Imaging; 2013; 12(5):338-47. PubMed ID: 23759374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NIR fluorescent probes with good water-solubility for detection of amyloid beta aggregates in Alzheimer's disease.
    Xu M; Li R; Li X; Lv G; Li S; Sun A; Zhou Y; Yi T
    J Mater Chem B; 2019 Sep; 7(36):5535-5540. PubMed ID: 31451829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
    Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and evaluation of curcumin-based fluorescent probes to detect Aβ fibrils.
    Sato T; Hotsumi M; Makabe K; Konno H
    Bioorg Med Chem Lett; 2018 Dec; 28(22):3520-3525. PubMed ID: 30297285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functionalized graphene-based electrochemical array sensors for the identification of distinct conformational states of Amyloid Beta in Alzheimer's disease.
    Ji H; Kang X; Yang X; Chen H; Zhu L; Mao T; He Y; Liu J; Wang Q; Zhou X; Li G; Wu M; Cong H; Wu L; Qin Y
    Biosens Bioelectron; 2023 Feb; 222():114927. PubMed ID: 36525707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
    Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G
    Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Versatile Dicyanomethylene-Based Fluorescent Probes for the Detection of β-Amyloid in Alzheimer's Disease: A Theoretical Perspective.
    Zhang M; Fu H; Hu W; Leng J; Zhang Y
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solvation-Guided Design of Fluorescent Probes for Discrimination of Amyloids.
    Cao KJ; Elbel KM; Cifelli JL; Cirera J; Sigurdson CJ; Paesani F; Theodorakis EA; Yang J
    Sci Rep; 2018 May; 8(1):6950. PubMed ID: 29725045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
    Kreutzer AG; Nowick JS
    Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of amyloid-β aggregation in Alzheimer's disease.
    Wang Q; Yu X; Li L; Zheng J
    Curr Pharm Des; 2014; 20(8):1223-43. PubMed ID: 23713775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of indane-based fluorescent probes for detection of amyloid-β aggregates in Alzheimer's disease.
    Lee H; Kim Y; Aziz H; Kang DM; Lee J; Lee S; Jung S; Hyeon S; Choo H; Nam G; Kim YK; Lim S; Min SJ
    Bioorg Med Chem; 2023 Nov; 95():117513. PubMed ID: 37931520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Positive Side of the Alzheimer's Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1.
    Ciccone L; Shi C; di Lorenzo D; Van Baelen AC; Tonali N
    Molecules; 2020 May; 25(10):. PubMed ID: 32456156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel D-π-A type near-infrared fluorescent probes for the detection of Aβ
    Lv G; Xu Y; Yang J; Li W; Li C; Sun A
    Analyst; 2020 Oct; 145(20):6579-6585. PubMed ID: 32780031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid beta-protein (Abeta) 1-40 but not Abeta1-42 contributes to the experimental formation of Alzheimer disease amyloid fibrils in rat brain.
    Shin RW; Ogino K; Kondo A; Saido TC; Trojanowski JQ; Kitamoto T; Tateishi J
    J Neurosci; 1997 Nov; 17(21):8187-93. PubMed ID: 9334394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.